Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2009, 153(3):199-203 | DOI: 10.5507/bp.2009.033
USE OF FORMOTEROL IN THE TREATMENT OF STUTTERING. A PILOT STUDY
- a Department of Biophysics, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic
- b ORL Department, District Hospital in Kromeriz, Czech Republic
Aims: Stuttering is a serious health and social problem that can distinctively affect not only the mental development of an individual but also his life possibilities, including social fulfilment and his general life prospects. The etiology of stuttering is however unknown and that is why it is not possible to treat it causally. This pilot study takes into account the hypothesis of bronchial constriction as a negative factor in stuttering and investigates the effect of the long-acting bronchodilator formoterol fumarate on stuttering in 42 patients.
Methods: Patients were divided in 2 groups - A (school children and juveniles) and B (adults 18-25 resistant to other treatment). The medicine was administered once a day in the morning in a dose of 12 µg for the total period of 6 months. The prime outcome parameter - severity of stuttering - was evaluated using the ordinary scale (McGill Pain Questionnaire). The evaluation was done by an examining physician during visits to the centres and by the patients themselves (in cases of the youngest with the assistance of a parent) in a daily diary.
Results: A non-parametric pair test (Wilcoxon signed rank test) was used to compare the average marks in the whole set of patients. During the six moth period of administration of Foradil® the speech fluency improved. The average number of dysfluent words decreased from 10.5 ± 1.3 to 6.6 ±0.97.
Conclusion: The average mark of speech fluency evaluated by the physicians between the period of non use of Foradil® and the six month period after the use of Foradil® improved from 2.95 ± 0.76 to 1.95 ± 0.56 (as proved by the chi-square test, p<0.0001). The evaluation of speech fluency of balbuties uses the logopedic practices. Other clinical evaluations of speech fluency are not known.
Keywords: Stuttering, Bronchodilatation, Formoterol (Foradil®)
Received: April 6, 2009; Accepted: September 1, 2009; Published: September 1, 2009 Show citation
References
- Lašťovka M. Poruchy plynulosti řeči. [Speech Fluency Disorders]. (In Czech). Scriptorium, spolek pro nekomerční vydávání odborné literatury. ISBN 80-86197-13-1, Praha 1999.
- Švédová P. Školáci řeší problémy sebevraždami. [Pupils deal with problems by suicide]. (In Czech). Olomoucký den, Příloha víkend, č. 131, 2004.
- Guitar B. Stuttering. An Integrated Approach to Its Nature and Treatment. 2nd edition, Wiliams & Wilkins, Baltimore, 1998.
- Adams RD, Victor M. Principles of Neurology. McGraw-Hill Information Services Company, Fourth Edition, New York, 1989.
- Bloodstein, O. Stuttering: The Search for a Cause and Cure. Allyn & Bacon, Boston 1993.
- Bloodstein O. A Handbook on Stuttering. Fifth Edition. Singular Publishing Group, Inc., San Diego London 1995.
- Seeman M. Poruchy dětské řeči. [Speech Disorders in Children]. (In Czech). Státní zdravotnické nakladatelství, Praha 1955.
- Pesak J. Funkcni vysetreni plic u deti a mladistvych s balbuties. [Examining the Function of Lungs in Children and Juveniles with Balbuties]. (In Czech). Cs. Pediatrie, 43, c. 7.
- Zapletal A, Šamánek M, Paul T. Funkce dýchacího ústrojí u dětí a mladistvých. [Function of Breathing Apparatus in Children and in Juvenils]. (In Czech). Osveta, Martin 1984.
- Pešák J. Hypotéza pneumoobstrukční etiologie koktavosti. [Hypothesis of Pneumoobstruction Etiology of Stuttering]. (In Czech). In: Sborník přednášek 9. Semináře univerzitního Společenství pro studium hlasu a řeči, Ed: Dr. Josef Pešák, Ústav lékařské biofyziky LF UP v Olomouci, květen 2002.
- Pešák J. Pneumoobstruction of the Tracheobronchial Tree as a Hypothetical Cause of Balbuties. Medical Hypotheses, 59 (4), 458- 461, 2002.
Go to original source...
Go to PubMed...
- Malzack R. The short-form McGill Questionnaire. Pain 1987 Aug; 30 (2): 191-197.
Go to original source...
Go to PubMed...
- Pattent No: CT/CZ2005/000026 Pouziti pripravku na bazi beta 2 sympatomimetika k omezeni koktavosti [The Use of Medicine Based on sz2 Sympatomimetik to Decrease Stuttering]. (In Czech).
- Fibiger S, et al. Health and human services for persons who stutter and education of logopedics in East-European countries. Journal of Fluency Disorders 33(2008)66-71 23.
Go to original source...
Go to PubMed...
- Pešák J. Preliminary experience with formoterol for treatment of stuttering. Letters and comments. Annals of Pharmacotherapy, Jul-Aug 2004, vol. 38, no 7-8, p. 13
Go to original source...
- Pešák J. Zmírňování zadrhávání v řeči u dětí a mladistvých s balbuties po aplikaci 2 sympatomimetika formoterol. [Decreasing stuttering in children and in juvenils after the aplication of 2 sympatomimetik formoterol]. (In Czech). Klin Farmakol Farm, 2004, roč. 18., s. 11-12
- Honová J, Pešák J. Ověřování vlivu bronchodilatace na plynulost řeči u nezletilých i dospělých s balbuties, Součást výzkumného záměru MSM 152100018. [Diagnosis the influence of bronchodilatation in speech fluency in juvenils and in adults with balbuties, Part of a research task. (In Czech). Protokol: BZ-1003-BR, Finální verze 03. 11. 03, ZAK-Pharma Services s.r.o., Brno, 2003.